Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Core Laboratories (CLB) Equity Average (2022 - 2026)

Core Laboratories filings provide 5 years of Equity Average readings, the most recent being $270.6 million for Q1 2026.

  • On a quarterly basis, Equity Average rose 6.89% to $270.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $270.6 million, a 6.89% increase, with the full-year FY2025 number at $259.2 million, up 8.73% from a year prior.
  • Equity Average hit $270.6 million in Q1 2026 for Core Laboratories, up from $268.7 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $270.6 million in Q1 2026 to a low of $178.5 million in Q3 2022.
  • Median Equity Average over the past 5 years was $241.6 million (2024), compared with a mean of $234.4 million.
  • Biggest five-year swings in Equity Average: increased 25.76% in 2023 and later increased 5.62% in 2025.
  • Core Laboratories' Equity Average stood at $183.4 million in 2022, then rose by 23.72% to $226.9 million in 2023, then rose by 12.1% to $254.4 million in 2024, then grew by 5.62% to $268.7 million in 2025, then increased by 0.71% to $270.6 million in 2026.
  • The last three reported values for Equity Average were $270.6 million (Q1 2026), $268.7 million (Q4 2025), and $269.3 million (Q3 2025) per Business Quant data.